COVID-19 Convalescent Plasma Program

C3PO Facilities VA CURES-1 Facilities

A world-renowned leader in infectious disease and transfusion medicine research, Vitalant Research Institute (VRI)—a division of Vitalant—is helping direct collection of blood plasma donations from recovered COVID-19 patients and developing technologies to detect and quantify virus-fighting antibodies. Recovered COVID-19 patients may have immune-boosting antibodies in their plasma; that plasma—called “convalescent plasma”—could be used to treat critically ill COVID-19 patients.

UPDATE! On Sunday, August 23, 2020, the U.S. Food and Drug Administration (FDA) issues an Emergency Use Authorization (EUA) for COVID-19 Convalescent Plasma (CCP) for the treatment of COVID-19 in hospitalized patients. Vitalant sent a communication to hospital partners on August 28, 2020 outlining what we know now about EUA impacts. View that communication here.

ISBT Codes and Labels for customers who receive CCP units from Vitalant:

CCP Product Label Examples

Apheresis CCP
Description ISBT 128 Code Label Example
Apheresis CONVALESCENT PLASMA|ACD-A/XX/<=-18C|COVID-19 E9747V00
Previously Provided
Label Example
Apheresis CONVALESCENT PLASMA|ACD-A/XX/<= -18C|Irradiated|COVID-19 E9753V00
Previously Provided
 
Thawed Apheresis CONVALESCENT PLASMA|ACD-A/XX/refg|COVID-19 E9752V00
Previously Provided
Label Example
Apheresis CONVALESCENT PLASMA|ACD-A/XX/<=-18C|1st container|COVID-19   E9754V00 Label Example
Apheresis CONVALESCENT PLASMA|ACD-A/XX/<=-18C|2nd container|COVID-19  E9755V00 Label Example
Apheresis CONVALESCENT PLASMA|ACD-A/XX/<=-18C|3rd container|COVID-19   E9756V00 Label Example
Apheresis CONVALESCENT PLASMA|ACD-A/XX/<=-18C|4th container|COVID-19    E9757V00 Label Example
 
Whole Blood Derived CCP
Description ISBT 128 Code Label Example
CONVALESCENT PLASMA|CP2D/XX/<=-18C|COVID-19 E9802V00 Label Example
CONVALESCENT PLASMA|CPD/XX/<=-18C|COVID-19 E9735V00 Label Example
CONVALESCENT PLASMA|CPDA-1/XX/<=-18C|COVID-19 E9804V00 Label Example
 
Psoralen Treated CCP
Description ISBT 128 Code Label Example
Apheresis CONVALESCENT PLASMA|ACD-A/XX/<=-18C|Psoralen-treated|COVID-19 E9771V00
Previously Provided

 

For customers recruiting potential CCP donors for qualification:

Donor Recruitment Flyer (English)
Donor Recruitment Flyer (Spanish)
Donor Recruitment Flyer Co-Branding Option (English)
Donor Recruitment Flyer Co-Branding Option (Spanish)
Click to download a PDF flyer to help recruit potential CCP donors.

Donor Recruitment Email/Letter Template
Click to download a Word document with suggested email/letter copy to help recruit potential CCP donors.

Donor Recruitment Social Media Copy
Click to download a Word document with suggested social media copy to help recruit potential CCP donors.

Social media graphics
Click to download graphics you can post on social media with the suggested copy.
 
Instagram Twitter Facebook
1474_convalescent_Insta.jpg 1474_convalescent_tw_-(2).jpg 1474_convalescenttrails_FB_.jpg

Frequently Asked Questions about Vitalant's Convalescent Plasma Program

How does a current, contracted hospital customer obtain convalescent plasma from Vitalant?
Once a contracted customer has worked with their local contact(s) and taken the necessary steps to be part of Vitalant’s convalescent plasma program, they can take the following steps to order CCP.
 
  1. Please consent your patient to receive CCP as per your institutional policy. You may call Vitalant prior to the consent of the patient to obtain an estimated time of arrival of CCP to your facility. The consent is not needed prior to distribution of CCP to your facility but is needed prior to transfusion.
  2. Please provide the blood type of your patient to Vitalant if ABO-compatible plasma is requested.
  3. Please have your blood bank staff order CCP units through their online portal.
  4. Please inform Vitalant Hospital Services of the blood type of CCP needed, or if you can accept a non-compatible CCP unit for your patient. A Vitalant Transfusion Medicine MD is available for consultation regarding transfusing incompatible plasma.
  5. If an additional unit is needed for your patient, please have your blood bank staff order online or call Vitalant Hospital Services to order the additional unit.
  6. Please obtain the emergency IND prior to transfusion of the unit if your facility is not under a traditional IND or the expanded access program through Mayo Clinic. This is not needed prior to distribution of the unit from Vitalant to your hospital.
How does a non-contracted hospital obtain convalescent plasma from Vitalant?
Non-contracted customers can reach out to Vitalant’s Inventory Management team at ProductManagement@vitalant.org  or to discuss potential convalescent plasma ordering.

Where can your organization get the most up-to-date information about convalescent plasma?
This website is where we will maintain up-to-date information about the convalescent plasma program. We will continue to send email communications with major updates and required actions but please use this webpage as a frequently-checked resource at your organization.

If your organization is interested in the emergency use of investigational COVID-19 convalescent plasma, we strongly recommend you visit the FDA’s webpage regarding “Recommendations for Investigational COVID-19 Convalescent Plasma” for more information about how your facility should work directly with the FDA to prepare.

Who should I contact at Vitalant about its convalescent plasma program?
If you represent a facility that has interest/need to transfuse active COVID-19 patients please reach out to your area’s Regional Account Manager and Medical Director with questions/inquiries.
 
For questions regarding reimbursement for CCP products under various INDs/programs, please reach out to your Vitalant contact.